ezetimibe has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armenoult, L; Ayadi, M; Barraud-Blanc, M; Bian, B; Bigonnet, M; Blum, Y; Boher, JM; Bories, E; Calvo, E; de Reyniès, A; Delpero, JR; Duconseil, P; Dusetti, N; Elarouci, N; Ewald, J; Garcia, S; Garnier, J; Gasmi, M; Gayet, O; Gilabert, M; Giovannini, M; Goncalves, A; Grandval, P; Guillaumond, F; Iovanna, J; Lomberk, G; Loncle, C; Maignan, A; Marisa, L; Moutardier, V; Nicolle, R; Norguet, E; Ouaissi, M; Poizat, F; Raoul, JL; Roques, J; Rubis, M; Secq, V; Turrini, O; Urrutia, R; Vasseur, S | 1 |
1 other study(ies) available for ezetimibe and Pancreatic Neoplasms
Article | Year |
---|---|
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Datasets as Topic; Ezetimibe; Humans; Male; Mice; Pancreatic Neoplasms; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2017 |